Trabectedin mechanism of action: what’s new?

By D’Incalci Maurizio  

Future Oncology, Vol. 9, Iss. 12, 2013-12 ,pp. : 5-10

Future Medicine

Access to resources Recommend Favorite

Trabectedin plus pegylated liposomal doxorubicin: the return of a treatment option for ovarian cancer

By Clare John  

Future Oncology, Vol. 9, Iss. 12, 2013-12 ,pp. : 1-1

Future Medicine

Access to resources Recommend Favorite

Anti-Cancer Activity of Nitrones and Observations on Mechanism of Action

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 4, 2011-05 ,pp. : 373-379

Bentham Science Publishers

Access to resources Recommend Favorite

Current View on the Mechanism of Action of Perifosine in Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 4, 2014-05 ,pp. : 629-635

Bentham Science Publishers

Access to resources Recommend Favorite

Trail activity in human ovarian cancer cells - potentiation of the action of cytotoxic drugs

By Vignati S.   Codegoni A.   Polato F.   Broggini M.  

European Journal of Cancer, Vol. 38, Iss. 1, 2002-01 ,pp. : 177-183

Elsevier

Access to resources Recommend Favorite